0001179110-14-013831.txt : 20140909 0001179110-14-013831.hdr.sgml : 20140909 20140909135316 ACCESSION NUMBER: 0001179110-14-013831 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140908 FILED AS OF DATE: 20140909 DATE AS OF CHANGE: 20140909 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celldex Therapeutics, Inc. CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 119 FOURTH AVE CITY: NEEDHAM STATE: MA ZIP: 02494 BUSINESS PHONE: 7814330771 MAIL ADDRESS: STREET 1: 119 FOURTH AVE CITY: NEEDHAM STATE: MA ZIP: 02494-2725 FORMER COMPANY: FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19980828 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CATLIN AVERY W CENTRAL INDEX KEY: 0001255348 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15006 FILM NUMBER: 141093004 MAIL ADDRESS: STREET 1: 241 CENTRAL STREET CITY: HINGHAM STATE: MA ZIP: 02043 4 1 edgar.xml FORM 4 - X0306 4 2014-09-08 0 0000744218 Celldex Therapeutics, Inc. CLDX 0001255348 CATLIN AVERY W C/O CELLDEX THERAPEUTICS, INC. 53 FRONTAGE ROAD HAMPTON NJ 08827 0 1 0 0 Sr. VP & CFO Common Stock 2014-09-08 4 M 0 10000 4.50 A 24609 D Incentive Stock Options 4.50 2014-09-08 4 M 0 10000 0.00 D 2013-01-21 2020-01-21 Common Stock 10000 17847 D As of January 21, 2014, the option was fully vested. Includes 500 shares acquired under the Celldex Therapeutics, Inc. 2004 Employee Stock Purchase Plan on July 02, 2014. /s/ Anthony S. Marucci, attorney in fact for Avery W. Catlin 2014-09-09